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Abstract
Background & Aims
Intestinal microfold (M) cells are specialized epithelial cells that act as gatekeepers of lumi-
nal antigens in the intestinal tract. They play a critical role in the intestinal mucosal immune
response through transport of viruses, bacteria and other particles and antigens across the
epithelium to immune cells within Peyer’s patch regions and other mucosal sites. Recent
studies in mice have demonstrated that M cells are generated from Lgr5+ intestinal stem
cells (ISCs), and that infection with Salmonella enterica serovar Typhimurium increases M
cell formation. However, it is not known whether and how these findings apply to primary
human small intestinal epithelium propagated in an in vitro setting.
Methods
Human intestinal crypts were grown as monolayers with growth factors and treated with
recombinant RANKL, and assessed for mRNA transcripts, immunofluorescence and uptake
of microparticles and S. Typhimurium.
Results
Functional M cells were generated by short-term culture of freshly isolated human intestinal
crypts in a dose- and time-dependent fashion. RANKL stimulation of the monolayer cultures
caused dramatic induction of the M cell-specific markers, SPIB, and Glycoprotein-2 (GP2)
in a process primed by canonical WNT signaling. Confocal microscopy demonstrated a
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pseudopod phenotype of GP2-positive M cells that preferentially take up microparticles.
Furthermore, infection of the M cell-enriched cultures with the M cell-tropic enteric patho-
gen, S. Typhimurium, led to preferential association of the bacteria with M cells, particularly
at lower inoculum sizes. Larger inocula caused rapid induction of M cells.
Conclusions
Human intestinal crypts containing ISCs can be cultured and differentiate into an epithelial
layer with functional M cells with characteristic morphological and functional properties.
This study is the first to demonstrate that M cells can be induced to form from primary
human intestinal epithelium, and that S. Typhimurium preferentially infect these cells in an
in vitro setting. We anticipate that this model can be used to generate large numbers of M
cells for further functional studies of these key cells of intestinal immune induction and their
impact on controlling enteric pathogens and the intestinal microbiome.
Introduction
The single layer of epithelial cells that lines the entire intestinal tract is the primary physical
barrier separating the intestinal lumen and its content from the intestinal lamina propria and
the body’s interior. Various mechanisms have been proposed to explain enteral uptake of
viruses and microbes, including disruptions of the epithelial barrier, transcytosis across entero-
cytes, infection of juxtaposed dendritic cells and/or lymphocytes, and through microfold (M)
cells located within the follicle-associated epithelium (FAE) that overlies Peyer’s patches [1], or
are scattered along the villus-independent of Peyer’s patches [2]. These cells represent a major
site for the sampling of gut luminal antigens, and are important for enteral uptake of various
commensal microorganisms, and viral and bacterial pathogens including Salmonella enterica
serovar Typhimurium, Vibrio cholerae, HIV, Reovirus, Poliovirus and others [1–4].
M cells lack the typical tightly packed long microvilli characteristic of enterocytes, and
instead have disorganized stubby microvilli along their apical border [2]. In addition, M cells
have deep basolateral invaginations that are often found to harbor immune cells. This mor-
phology allows for efficient antigen and microbial sampling along with rapid transcytosis.
Thus far, the assessment of how various pathogens are transmitted across the human intestinal
epithelial layer has been limited to immortalized colon cancer cell lines [5–7].
All epithelial cells of the gut are derived from dividing crypt-based intestinal stem cells
(ISCs) that undergo long-term self-renewal to maintain the stem cell population and are
uniquely identified by expression of Lgr5 [8]. The differentiated epithelial lineages of the small
intestine include Paneth cells, goblet cells, tuft cells, enterocytes, enteroendocrine cells, and M
cells, all of which have specialized roles required for proper alimentation within the context of
a complex symbiotic luminal microbiota. By nature, the ISCs are particularly sensitive to injury
under stressful conditions including infection; however, a quiescent cell population of secretory
progenitor cells (+4 cells) can de-differentiate into bona fide LGR5+ rapidly dividing ISCs [9].
Under both homeostatic and stressed conditions, the function of ISCs and the quiescent +4 cell
are believed to be influenced by various cells within the niche–including subepithelial myofi-
broblasts, lymphocytes, macrophages, and dendritic cells.
Epithelial lineage differentiation in the small intestine is controlled a complex cascade of
lineage-specific transcription factors that are activated by the Notch signaling pathway in ISCs
Functional M Cells from Human Intestinal Stem Cells
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and early progenitor cells which dictates differentiation into absorptive or secretory cell line-
ages [10–12]. Furthermore, lineage differentiation is influenced by the cellular microenviron-
ment. For example, development of M cells located within the FAE is controlled in mice by a
subepithelial network of reticular cells and B cells that secrete the cytokine, receptor activator
of NF-κB ligand (RANKL)—a type II member of the tumor necrosis factor superfamily [13].
The binding of RANKL to its receptor, RANK (TNFRSF11a), activates the non-canonical
(RelB) NF-κB signaling pathway, and induces the expression of SpiB, an ETS-transcription fac-
tor that drives M cell fate determination and maturation [14–16].
Recent studies have demonstrated that M cells can be generated using a murine in vitro
enteroid model in a RANKL-dependent manner [17]. Lineage-tracing studies demonstrated
that M cells are derived from LGR5+ ISCs through RANKL induction of SpiB. RANKL stimu-
lation of LGR5+ crypts from SpiB null mice failed to generate M cells, confirming that SpiB
expression is required for M cell development [17]. In addition, acute S. Typhimurium infec-
tion in mice has been shown to induce rapid transdifferentiation of enterocytes into functional
M cells through WNT/β-catenin and NF-κB dependent epithelial mesenchymal transition
(EMT) [16]. This follows similar patterns of EMT observed in other cell types through the
sameWNT/β-catenin and NF-κB signaling pathways [18–20].
Intestinal enteroids are an in vitromodel that supports the proliferation and differentiation
of ISCs into the full array of epithelial lineages that comprise the lining of the gut [8]. Several
groups, including our own, have developed methods to grow human enteroids including in a
2D modular configuration using Transwells that separates luminal and subepithelial compart-
ments [21,22]. Here we set out to adapt the enteroid model for the formation of M cells from
proximal human small intestinal crypts, and characterize the cells in regard to their ability to
endocytose microparticles and permit uptake of S. Typhimurium, both of which are character-
istics of M cells in vivo.
Results
RANKL-Induces M Cell Differentiation in a Dose- and Time-Dependent
Fashion
Primary human intestinal crypts isolated from discarded surgical samples of the proximal
small intestine were grown on both 2D collagen-coated plates, and as 3DMatrigel plugs in
ENRY medium that promotes their growth [22,23] with and without addition of recombinant
RANKL every other day. RANKL stimulated a marked increase in SPIB expression at each con-
centration tested in 2D-grown monolayers when compared to proximal whole small bowel
controls [Fig 1A]. Similarly, RANKL promoted expression of GP2, a cell surface marker specifi-
cally expressed on M cells and absent on other ISC-derived cells [24] in a concentration- and
time-dependent manner [Fig 1A]. Increased expressed of SPIB and GP2 were first evident at
day 4 and peaked at day 7 following RANKL exposure [Fig 1B, data not shown]. Similar results
were obtained when enteroids were grown in 3D configuration (data not shown).
Next we examined the timing of the RANKL effects on M cell formation. Two doses of
RANKL on days 0 and 2 generated the highest expression of the M cell markers, SPIB and GP2,
as assessed at varying times after RANKL exposure, whereas a single dose or three doses led to
lower expression [Fig 1C]. In all dosing variations, a progressive decrease of both SPIB and
GP2 expression was observed at longer times after the final RANKL exposure [Fig 1C].
Together, these data show that RANKL stimulates expression of M cell associated transcripts
in human enteroids in a concentration- and time-dependent manner that is maximally effec-
tive when added for a limited time early in culture.
Functional M Cells from Human Intestinal Stem Cells
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The induction of M cell-specific transcripts was paralleled by increased protein expression,
as shown by immunofluorescence staining for GP2 [Fig 2A]. Of the cells identified by DAPI
nuclear staining, 36.0 ± 12.9% were positive for GP2 in the RANKL-treated group, compared
to only 0.2 ± 0.4% in the untreated controls (p<0.005). The majority of the M cells were
observed near the periphery of cell islands within the monolayers. Control staining for
EPCAM, a ubiquitous epithelial cell surface marker, confirmed that the epithelial nature of
majority of cells in the monolayer [Fig 2A]. Closer examination of the RANKL treated mono-
layer cultures by confocal microscopy revealed that the GP2-positive M cells when grown in
2D exhibited pseudopod-like cell surface structures extending from the membrane [Fig 2B].
Fig 1. RANKL induces M cell differentiation in a dose and time dependent manner. (A) Dose-dependent increases of SPIB andGP2mRNA expression
in 50, 100 and 200 ng/mL RANKL and ENRY treated monolayers assessed at day 5. (B) Time course of SPIB andGP2 peaked expression levels in
monolayers treated with and without 200ng/mL RANKL. (C) Time decay of SPIB andGP2 expression among monolayers receiving 0, 1, 2, or 3 doses of
RANKL every other day from day 0, and assessed on days 7, 9, 11 and 13. All results normalized toGAPDH expression in human whole proximal small
bowel or crypts, as indicated. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
doi:10.1371/journal.pone.0148216.g001
Functional M Cells from Human Intestinal Stem Cells
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Fig 2. RANKL induces M cell surface marker presence and typical morphology. (A) Epifluorescense
imaging (100Xmagnification) of human intestinal monolayers showing uniform expression of epithelial cell
surface marker EPCAM in no RANKL and RANKL-treated monolayers, confirming epithelial origin. This is in
Functional M Cells from Human Intestinal Stem Cells
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Furthermore, the cells lacked the uniformity of epithelial cells seen by EPCAM staining of non-
RANKL treated cultures [Fig 2B].
Canonical WNT Primes Stem Cells for RANKL-Induced M Cell
Formation
In vitro expansion of human enteroids is known to require canonical-WNT stimulation where
R-spondin (RSPO) is indispensable, while WNT3a, and/or the GSK-3β inhibitor, CHIR99021
(GSKi) enhance robust growth [21,22,25]. RSPO, a potent inducer of the canonical-WNT path-
way, significantly potentiated the time-dependent increase in SPIB and GP2 expression when
used alone even in the absence of RANKL [Fig 1B] [26]. To further assess the consequences of
canonical-WNT on M cell differentiation, two experiments were performed. The first exam-
ined the effect of GSKi with and without RANKL, while the second determined the effect of
various doses of WNT3a prior to passaging the cells in the presence or absence of RANKL.
GSKi that was added on day 0 in the absence of RANKL increased GP2 and SPIB transcripts
by six-fold at an early time point (day 4) [Fig 3A]. By day 7, however, the ENRY only group
(without GSKi) reached the same levels of GP2 and SPIB expression, which suggests the possi-
ble role of RSPO synergism at later time points [Fig 3A]. As shown above, however, RANKL
administration was required to achieve>100-fold enhanced ability for monolayers to formM
cells [Fig 3A].
To further examine the consequences of WNT3a signaling, monolayers were grown with
ENRY and treated for 7 days with various doses of WNT3a prior to passaging the cells in either
the presence or absence of RANKL; cultures were assessed 5 days later. Monolayers treated
with RANKL and 5%WNT3a-conditioned media (WNT3a-CM) showed the greatest M cell
formation, as SPIB and GP2 expression were 130- and 120-fold higher than controls, respec-
tively [Fig 3B]. This is in comparison to the 0%WNT3a-CM group where SPIB and GP2
mRNA levels increased 70 and 100-fold, and 50%WNT3a-CM group to 95- and 20-fold over
controls, respectively [Fig 3B]. Without RANKL administration, all groups showed lower levels
of expression compared to control samples. Taken together, these data suggest that the process
of M cell differentiation is augmented through the canonical WNT signaling pathway, but that
RANKL is required to induce a more robust differentiation process.
Cultured M Cells Demonstrate Functionality with Increased Microparticle
Uptake
M cells have a high capacity to endocytose and transcytose particulates [27]. Utilizing the same
mechanisms that facilitate viral and bacterial transcytosis, M cells take up nanospheres as small
as 20 nm, and microparticles as large as 10 μm [27]. The highest uptake rates are observed with
particles of 1 μm diameter [28,29]. To explore the endocytic properties of in vitro derived
human M cells, we incubated RANKL-treated monolayer cultures with fluorescent latex micro-
particles (1 μm) and performed confocal microscopy after 60–120 minutes. Microparticles
were observed within GP2-positive cells using a Z-stack projection [Fig 4A]. By comparison,
non-RANKL treated monolayers stained with the ubiquitous epithelial marker, E-cadherin,
showed a lack of any microparticle uptake [Fig 4B]. Quantification by epifluorescence
comparison to M cell surface marker GP2 absence in no RANKL group versus positive GP2 staining in
RANKLmonolayer groups. (B) Confocal microscopy assessment (400Xmagnification) of immunostained
RANKL treated monolayers showing membrane surface and cytoplasmic GP2 staining, demonstrating the
characteristic M cell morphology of pseudopod-like projections (white arrows). Scale bar 100 μm.
doi:10.1371/journal.pone.0148216.g002
Functional M Cells from Human Intestinal Stem Cells
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microscopy confirmed significantly greater (18-fold) microparticle uptake in RANKL-treated
monolayer cultures compared to the non-RANKL treated group [Fig 4C].
Preferential Uptake of S. Typhimurium into Cultured M Cells
M cells function as a gateway for many bacterial and viral pathogens to initiate host infection.
For example, S. Typhimurium exploits the phagocytic properties of M cells by preferentially
adhering to and entering M cells in the intestinal mucosa [3,27]; however, this has never been
shown with primary human cells To further explore the utility of our M cell model, we infected
RANKL-treated and untreated monolayers with GFP-labeled S. Typhimurium for 1 h, washed
the cultures, and incubated them for an additional hour with gentamicin to kill the remaining
Fig 3. Canonical-WNT signal primes ISCs for RANKL inducedM cell differentiation (A) Time course of SPIB andGP2 peaked expression levels in
monolayers treated with and without 200ng/mL RANKL. (B) Cells were treated with 0%, 5%, and 50%WNT3a-CM for 7 days, and on day 0 and 2 of the
subsequent passage, cells were treated with ±200ng/mL RANKL and assessed 5 days later. All samples received ENRY complete medium and were
assessed by quantitative PCR; all results normalized toGAPDH expression in human whole small bowel or crypts, as indicated. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001.
doi:10.1371/journal.pone.0148216.g003
Functional M Cells from Human Intestinal Stem Cells
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Fig 4. RANKL treatedmonolayers demonstrate functional M cells through uptake of fluorescent 1μmTexas Red latex microparticles. (A) Confocal
microscopy z-stack assessment (400Xmagnification) showing colocalization of fluorescent 1μm Texas Red latex microparticles and GP2 positive stained M
cells with enlarged sections [x,y] showing clumping of microparticles. (B) Confocal microscopy section (400X magnification) of non-RANKL monolayer
stained for E-cadherin (CDH1), a cell surface marker that M cells lack, demonstrating uniform and ubiquitous staining, as well as lack of any Texas Red
Functional M Cells from Human Intestinal Stem Cells
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extracellular bacteria. Among RANKL untreated monolayers, there was very limited bacterial
uptake in the 10^5 and 10^6 inocula, but a more generalized cellular uptake in the 10^7 inocu-
lum [Fig 5A]. When compared to RANKL treated groups, bacteria were preferentially associ-
ated with GP2-positive M cells over a range of inocula [Fig 5B–5D]. Specifically, low (10^5 and
10^6) inocula non-M cells show a very low predilection for bacterial uptake, whereas, normal-
ized to cell density, M cells were 50 and 65-fold more likely to contain S. Typhimurium [Fig
5B–5D]. In other words, virtually all S. Typhimurium bacteria were localized within M cells in
these lower inocula. However, high inoculum (10^7) cultures show some bacterial co-localiza-
tion both non-M cells and M cells. The key difference is that M cells in the high inoculum cul-
ture demonstrate a significantly higher density of bacterial sampling, containing many bacteria
in each cell [Fig 5C]. Taken together, this data suggest that M cells preferentially endocystose S.
Typhimurium bacteria, but at a critical concentration, invasion of non-M cells becomes
possible.
S. Typhimurium Induces M Cell Differentiation
Bacterial challenge, specifically with S. Typhimurium, in bovines was shown to induce rapid
(<1 h) transdifferentiation of enterocytes to M cells in the presence of RANKL through the
canonical-WNT pathway in a process mediated by the bacterial effector SopB [16]. While cul-
tures infected with the lower inocula (10^5 and 10^6) had a similar proportion of M cells com-
pared to uninfected control cultures, monolayers infected with the highest inoculum (10^7)
showed a near doubling of the number of GP2+ cells within 1 h after infection [Fig 5E]. It
shows for the first time that the transition is cell-autonomous without a requirement for other,
non-epithelial cell types.
Discussion
We have developed a robust human in vitromodel that is enriched for M cells grown from
crypts of the proximal small intestine. The cultured M cells demonstrate several of the charac-
teristic mRNA transcripts and cell surface markers of M cells in vivo, as well as the capability to
internalize microparticles and bacteria such as S. Typhimurium. To the best of our knowledge,
this is the first report of a tractable human M cell model system.
We have previously shown that human intestinal enteroids can be grown from discarded
surgical samples and propagated indefinitely by weekly passage [21,22,25]. Cells in this system
retained the ability to differentiate into different epithelial lineages representative of crypt and
villi, but they lacked M cell markers under typical culture conditions. This current study
expands upon our previous work by demonstrating that functional M cells can be generated in
culture in a robust manner that recapitulates human M cells formation and function in vivo.
Most M cell studies have focused on FAE, which overlies Peyer’s patches and is part of a
continuous epithelial layer of the small intestine. In murine studies, M cell fate is dependent on
RANKL stimulation, which induces the expression of SpiB through the WNT/β-catenin
pathway [13,14,16]. Bacterial mediated mechanisms have also been shown to exploit the
WNT/β-catenin pathway to induce rapid de novo M cell formation through a process of epi-
thelial mesenchymal transition [16]. This study confirms prior knowledge that activation of
the canonical-WNT pathway primes M cell differentiation; however, ultimate M cell differenti-
ation is entirely dependent on RANKL through the NF-κB pathway [16]. Specifically, our data
microparticle internalization. (C) RANKL treated monolayers show significantly increased numbers of retained fluorescent microparticles after washing, as
assessed by three random high power field areas under confocal microscopy z-stack projections (400x). Scale bar 50 μm. ****p<0.0001.
doi:10.1371/journal.pone.0148216.g004
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Fig 5. Cultured M cells preferentially uptake S. Typhimurium. (A) Epifluorescense imaging (100X) of monolayers without RANKL inoculated with 10^5,
10^6 and 10^7 CFUs of wild type GFP- S. Typhimurium. (B) Epifluorescense imaging (100X) of a RANKL treated monolayer inoculated with 10^6 CFUs of
wild type GFP- S. Typhimurium showing uptake within GP2 stained cells, and respective magnification [x,y] showing clumping of many GFP-bacteria within
Functional M Cells from Human Intestinal Stem Cells
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suggest significant induction of SPIB transcription activity even without RANKL stimulation
in control groups receiving either RSPO alone or in combination with GSKi [Figs 1 and 3A].
However, exogenous RANKL is required to achieve optimal levels of SPIB activity to drive M
cell generation. As expected, low dose WNT3a showed higher M cell marker expression com-
pared to higher doses, likely because overstimulation with canonical WNT attenuates the more
fully differentiated state [Fig 3B].
Consistent with work done in mice, our data shows that the SPIB expression peaks after 2
days of RANKL administration, with GP2 levels peaking at day 4, and persisting through day 7
[Fig 3A, data not shown] [17]. We show that optimal RANKL delivery was at a concentration
of 200 ng/mL administered at day 0 and day 2 only, while repeat dosing failed to further
enhance M cell generation [Fig 1C].
In our monolayer cultures, we found evidence of deep pockets within M cells combined
with pseudopod extensions [Fig 2B]. Additionally, we noticed a trail of GP2 staining adjacent
to many of the M cells, and since GP2 selectively binds to the FimH component of the type I
pili of S. Typhimurium and other pathogens, we expected to find bacteria adjacent to and
within M cells [2]. This could possibly suggest GP2 shedding during the course of M cell move-
ment toward the periphery, which may be related to typical movement along the FAE.
A crucial feature of M cells is their role as antigen sampling and transcytotic sites. Micropar-
ticles have been targeted to M cells in in vivo animal studies for vaccine, adjuvant therapy and
drug delivery [27]. Multiple reports have characterized size parameters for uptake into M cells,
showing they are capable of taking up particles from 50 nm to 10 μm, although particles in the
0.5–2 μm range are transcytosed most effectively [28,29]. We observed clumping of microparti-
cles within M cells—suggesting that multiple particles may reside in the same phagosome. The
ability to create M cells from human intestinal crypts that have functional uptake of micropar-
ticles may improve high-throughput methods for optimization of vaccine and drug delivery
[27,30].
Many invasive bacteria cross the mucosal barrier often by exploiting the transcytotic ability
of M cells and occasionally can be spread hematogenously [31–34]. S. Typhimurium not only
invades M cells, but also through secretion of a type III effector protein named SopB, induces
rapid differentiation of FAE enterocytes into M cells [16]. Interestingly, this occurs through
inhibition of GSK3β, or the same β-catenin mediated mechanism as described above that we
utilized to prime ISCs for M cell development [Fig 3A]. SopB was found to induce both the
RANKL and the receptor RANK via WNT signaling, and was able to cause enterocyte transi-
tion within 60–180 minutes [16]. Specifically, SopB secreted by S. Typhimurium and other
pathogens induce rapid transdifferentiation of enterocytes into M cells via EMT. However, in
the bovine model, SopB-induced transition to M cells was limited to FAE crypts and was not
observed in ordinary crypts [16]. In contrast, we found that increases in the density of S. Typhi-
murium delivery was associated with an increases in M cell number in non-FAE crypts isolated
from the proximal bowel [Fig 5E]. The ability of proximal bowel crypts to be responsive to
RANKL would suggest the presence of its receptor, RANK, or other important components of
the signaling pathway in epithelium that might be capable of differentiating to M cells. Further
experiments with increasing time of Salmonella presence would further characterize the time
course of M cell transition that occurs with SopB presence.
the cell border. (C) Epifluorescense imaging (100X) of a RANKL treated monolayer inoculated with 10^7 CFUs of wild type GFP- S. Typhimurium showing
increased overall GFP- S. Typhimurium uptake in clusters containing M cells [x,z] compared to non-M cell cluster [y]. (D) Normalized to cell density per high
power field, S. Typhimurium bacteria were specifically associated with GP2-positive M cells in all inocula (log10 scale). (E) High inoculum S. Typhimurium
associated with an increased number of M cells after only 60 minutes of bacterial presence; Scale bar 100μm;*p<0.05, **p<0.01, ***p<0.001,
****p<0.0001.
doi:10.1371/journal.pone.0148216.g005
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The putative WNT source within the gut is more prominent within the niche located in the
crypt base, and one might anticipate that since FAE are flat dome-like structures without the
typical villus structure, that WNT signaling may be potent throughout [35]. However, the
requirement of WNT/RANKL signaling to generate M cells would suggest that along the villus
length in non-dome structures, M cells may differentiate at the crypt base and whether it
retains M cell feature once these signals diminish would need to be addressed. Nevertheless,
the lymphoid follicles in the gut are enriched with B cell expressing RANKL and their abun-
dance and proximity likely accounts for the enrichment of M cell within the FAE. Additional
assessments should include whether M cells generated from non-FAE crypts have a mesenchy-
mal phenotype, and whether EMT or MET are common fates outside of the FAE during
homeostatic and disease states such as during chronic inflammation or infection such as in
environmental enteropathy will require further assessments using similar in vitromodel
systems.
Material and Methods
Ethics Statement
All human tissues used in this study were obtained from de-identified and discarded surgical
specimens following clinical surgical pathology evaluation. This was approved by the Univer-
sity of California Los Angeles Institutional Review Board approved procurement and use of
surgical samples, which waived the requirement for informed consent for tissues obtained
from the UCLA Translational Pathology Core Laboratory (IRB #11–002504).
Intestinal Crypt Isolation
Small intestinal crypts were isolated as previously described [21,23]. Briefly, crypts were resus-
pended in basic medium (Advanced Dulbecco's Modified Eagle Medium (ADMEM)/Ham's
F12 (Invitrogen) with 2 mM GlutaMAX (Invitrogen), 10 mMHEPES (Invitrogen). Crypt yield
was determined by microscopic counting.
Cell Culture
A thin film of liquid type I collagen (Advanced BioMatrix, San Diego, CA) was plated onto the
bottom surface of 48-well Nucleon Delta-treated cell culture plate (Thermo Scientific, Wal-
tham, MA) at a concentration of 100 ng/mL, incubated for 30 minutes, and then removed by
aspiration. Human crypts were plated at a density of 500 crypts per well. These were grown as
monolayers in Basic Medium with antibiotic-antimycotic (Invitrogen), 1 mMN-Acetylcysteine
(Sigma), 100 ng/ml recombinant murine Noggin (PeproTech), 50 ng/ml recombinant murine
EGF (PeproTech), 1xN2 supplement (Invitrogen), 1xB27 supplement (Invitrogen), 1 μg/ml
recombinant human R-spondin 1 (R&D Systems, Minneapolis, MN), 10 μMY-27632 inhibitor
(Stemgent), 1 mM recombinant human Jagged-1 (R&D Systems), 5 μMCHIR99021 (GSK-3β
inhibitor) (Stemolecule). Alternatively, crypts were suspended within Matrigel at a concentra-
tion of 100 crypts per 25 μl of Matrigel and plated in 3D on the 48-well Nucleon Delta-treated
cell culture plate.
RANKL Stimulation
Cells were divided into groups and recombinant human RANKL (Peprotech, Rocky Hill, NJ)
added at different concentrations (50–200 ng/mL). Controls were left without RANKL. Fresh
culture medium, growth factors and RANKL were given at day 0 and replaced every 2 days
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until cultures were fixed for histologic or RNA analysis. Growth of two-dimensional monolay-
ers and three-dimensional structures were assessed using inverted light microscopy.
Subculturing of Human Monolayers
To examine the effect of WNT3a priming, a subset of monolayer cultures were treated with
0%, 5%, and 50% L-WNT3a conditioned medium (WNT3a CM), which was prepared as previ-
ously described, for 7 days [36]. After seven days of WNT3a-CM treatment, monolayers were
digested using TrypLE (Life Technologies) at 37°C for three minutes. TrypLE was then
quenched using 10% FBS in ADMEM/F12 and structures were mechanical split into small clus-
ters of cells. In a 1:2 or 1:3 split, cell cluster were re-plated onto collagen-coated plates and split
into 0%, 5% and 50%WNT3a-CM groups with and without 200 ng/mL RANKL.
Microparticle Uptake
After 4 days of culture, 1x105 1 μm fluorescent-Texas Red polystyrene microparticles (Thermo
Scientific) were added to monolayers and incubated for 60–120 minutes (Figs A-C in S1 File).
Each well was then washed with PBS three times to remove non-adherent microparticles, and
cultures were fixed with 3.4% formalin. Epifluorescence imaging was used to quantify micro-
particle uptake in three randomly chosen high power fields in RANKL treated and non-treated
groups.
Immunofluorescence and Confocal Microscopy
Monolayers cultured with and without latex microparticles were stained for Glycoprotein-2
(GP2) (MBL), E-cadherin (CDH1) (Dako), and Epithelial cell adhesion molecule (EPCAM)
(Abcam). Epifluorescence microscopy was used to characterize differences between RANKL
treated and non-treated groups. Confocal microscopy was used to characterize morphologic
characteristics, as well as confirm z-stack co-localization of Texas Red latex microparticles
within cells.
S. Typhimurium Inoculation
After 4–9 days of culture, RANKL treated and untreated monolayers were inoculated with dif-
ferent inocula of GFP-labelled S. Typhimurium [37]. Antibiotics were removed by repeated
washing before infections. Monolayers were then inoculated with 10^5, 10^6 and 10^7 CFU of
GFP-labeled bacteria. After 1 h, plates were incubated with gentamicin for 15–60 mins, and
washed three times with PBS. Monolayers were then fixed with 3.4% formalin for 5 mins.
Monolayers were stained for GP2 and DAPI, and epifluorescence imaging was used to
quantify GFP-labeled Salmonella inside GP2-positive cells as well as in non-GP2 stained cells
in three randomly chosen high power fields.
RNA Analysis
At various time points, monolayer and three-dimensional cultures were harvested, and mes-
senger RNA (mRNA) was isolated using Trizol Reagent (Life Technologies) method. Reverse
transcriptase polymerase chain reaction (RT-PCR) was performed to characterize expression
of GP2, SPIB, Chromogranin A (CHGA), and Glyceraldehyde-3-phosphate dehydrogenase
(GADPH). RT-PCR reactions were performed on a Prism 7900 HT Sequence Detection System
(Applied Biosystems). Cycle numbers were analyzed according to the comparative CT method
using GAPDH as the internal calibrator and human intestinal crypts as the reference tissue
[23].
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Statistical Analysis
Two-tailed unpaired student's t-test was used to compare results, and associated p-values are
reported.
Supporting Information
S1 File. Texas red microparticles and Human ISC monolayers. (Fig A) Epifluorescense
+ light microscopy (25X) of a 2μL droplet of 1μm Texas red microparticles, and epifluorescense
imaging (100X) of microparticles only pre- and post-washing demonstrating that microparti-
cles can be washed away. (Fig B) Light microscopy (25X) of confluent monolayer of RANKL
untreated and treated cells. (Fig C) Epifluorescense and light microscopy (100X) of RANKL-
untreated and -treated monolayers incubated with Texas red microparticles and washed thrice
showing greater microparticle presence in RANKL-treated group.
(TIF)
Author Contributions
Conceived and designed the experiments: JR AS NL EHMS JD LE MM. Performed the experi-
ments: JR AS NL SS JW EHMK LE. Analyzed the data: JR AS NL SS EHMKMLMS JD LE
MM. Contributed reagents/materials/analysis tools: ML MS JD LE MM. Wrote the paper: JR
AS MM. Critical review of the manuscript: JR AS NL SS MLMS JD LE MM.
References
1. Amerongen HM, Weltzin R, Farnet CM, Michetti P, HaseltineWA, Neutra MR. Transepithelial transport
of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. Journal of acquired immune defi-
ciency syndromes (1999). 1991; 4(8):760–5.
2. Neutra M, Frey A, Kraehenbuhl J. Epithelial M cells: gateways for mucosal infection and immunization.
Cell. 1996; 86(L):345–8.
3. Gonzalez-Hernandez MB, Liu T, Payne HC, Stencel-Baerenwald JE, Ikizler M, Yagita H, et al. Efficient
norovirus and reovirus replication in the mouse intestine requires microfold (M) cells. Journal of virol-
ogy. 2014 Jun; 88(12):6934–43. doi: 10.1128/JVI.00204-14 PMID: 24696493
4. Amerongen HM, Weltzin R, Mack JA, Winner LS, Michetti P, Apter FM, et al. M cell-mediated antigen
transport and monoclonal IgA antibodies for mucosal immune protection. Annals of the New York Acad-
emy of Sciences. 1992; 664:18–26. PMID: 1456648
5. Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl J-P. Transepithelial transport of
HIV-1 by M cells is receptor-mediated. Proceedings of the National Academy of Sciences of the United
States of America. 2002; 99(14):9410–4. PMID: 12093918
6. Fantini J, Yahi N, Chermann JC. Human immunodeficiency virus can infect the apical and basolateral
surfaces of human colonic epithelial cells. Proceedings of the National Academy of Sciences of the
United States of America. 1991; 88(20):9297–301. PMID: 1718004
7. Kerneis S. Conversion by Peyer’s Patch Lymphocytes of Human Enterocytes into M Cells that Trans-
port Bacteria. Science. 1997 Aug 15; 277(5328):949–52. PMID: 9252325
8. Sato T, Vries RG, Snippert HJ, van deWetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells
build crypt-villus structures in vitro without a mesenchymal niche. Nature. Nature Publishing Group;
2009 May 14; 459(7244):262–5. doi: 10.1038/nature07935 PMID: 19329995
9. Buczacki SJ a, Zecchini HI, Nicholson AM, Russell R, Vermeulen L, Kemp R, et al. Intestinal label-
retaining cells are secretory precursors expressing Lgr5. Nature. 2013; 495(7439):65–9. doi: 10.1038/
nature11965 PMID: 23446353
10. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, et al. Control of endodermal endo-
crine development by Hes-1. Nature genetics. 2000; 24(1):36–44. PMID: 10615124
11. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage
commitment in the mouse intestine. Science (New York, NY). 2001; 294(5549):2155–8.
12. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the
fate of immature progenitor cells in the intestine. Nature. 2005; 435(7044):964–8. PMID: 15959516
Functional M Cells from Human Intestinal Stem Cells
PLOS ONE | DOI:10.1371/journal.pone.0148216 January 28, 2016 14 / 16
13. Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, Nochi T, et al. RANKL is necessary and suffi-
cient to initiate development of antigen-sampling M cells in the intestinal epithelium. Journal of immu-
nology (Baltimore, Md: 1950). 2009; 183(9):5738–47.
14. Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, et al. The Ets transcription factor Spi-
B is essential for the differentiation of intestinal microfold cells. Nature Immunology. 2012; 13(8):729–
36. doi: 10.1038/ni.2352 PMID: 22706340
15. Kobayashi a, Donaldson DS, Erridge C, Kanaya T, Williams IR, Ohno H, et al. The functional matura-
tion of M cells is dramatically reduced in the Peyer’s patches of aged mice. Mucosal immunology.
Nature Publishing Group; 2013 Sep; 6(5):1027–37. doi: 10.1038/mi.2012.141 PMID: 23360902
16. Tahoun A, Mahajan S, Paxton E, Malterer G, Donaldson DS, Wang D, et al. Salmonella transforms folli-
cle-associated epithelial cells into M cells to promote intestinal invasion. Cell host & microbe. 2012 Nov
15; 12(5):645–56.
17. De LauW, Kujala P, Schneeberger K, Middendorp S, Li VSW, Barker N, et al. Peyer’s patch M cells
derived from Lgr5(+) stem cells require SpiB and are induced by RankL in cultured “miniguts”. Molecu-
lar and cellular biology. 2012 Sep; 32(18):3639–47. doi: 10.1128/MCB.00434-12 PMID: 22778137
18. Odero-Marah V a, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, et al. Receptor activator of NF-kappaB
Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate
cancer cells. Cell research. 2008; 18(8):858–70. doi: 10.1038/cr.2008.84 PMID: 18645583
19. Min C, Eddy SF, Sherr DH, Sonenshein GE. NF-kB and epithelial to mesenchymal transition of cancer.
Journal of Cellular Biochemistry. 2008; 104(3):733–44. doi: 10.1002/jcb.21695 PMID: 18253935
20. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3β-mediated
phosphorylation in control of epithelial–mesenchymal transition. Nature Cell Biology. 2004; 6(10):931–
40. PMID: 15448698
21. Lahar N, Lei NY, Wang J, Jabaji Z, Tung SC, Joshi V, et al. Intestinal subepithelial myofibroblasts sup-
port in vitro and in vivo growth of human small intestinal epithelium. PloS one. 2011; 6(11):e26898. doi:
10.1371/journal.pone.0026898 PMID: 22125602
22. Wang F, Scoville D, He XC, Mahe MM, Box A, Perry JM, et al. Isolation and characterization of intesti-
nal stem cells based on surface marker combinations and colony-formation assay. Gastroenterology.
2013; 145(2):383–95. doi: 10.1053/j.gastro.2013.04.050 PMID: 23644405
23. Jabaji Z, Brinkley GJ, Khalil H a, Sears CM, Lei NY, Lewis M, et al. Type I collagen as an extracellular
matrix for the in vitro growth of human small intestinal epithelium. PloS one. 2014; 9(9):e107814. doi:
10.1371/journal.pone.0107814 PMID: 25222024
24. Terahara K, Yoshida M, Igarashi O, Nochi T, Pontes GS, Hase K, et al. Comprehensive gene expres-
sion profiling of Peyer’s patch M cells, villous M-like cells, and intestinal epithelial cells. Journal of immu-
nology (Baltimore, Md: 1950). 2008; 180(12):7840–6.
25. Jabaji Z, Sears CM, Brinkley GJ, Lei NY, Joshi VS, Wang J, et al. Use of Collagen Gel as an Alternative
Extracellular Matrix for the In Vitro and In Vivo Growth of Murine Small Intestinal Epithelium. Tissue
Engineering: Part C. 2013; 19(12):961–9.
26. De LauWB, Snel B, Clevers HC. The R-spondin protein family. Genome Biology. 2012; 13(3):242. doi:
10.1186/gb-2012-13-3-242 PMID: 22439850
27. Ermak T, Giannasca P. Microparticle targeting to M cells. Advanced drug delivery reviews. 1998 Dec 1;
34(2–3):261–83. PMID: 10837681
28. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparti-
cles: Effect of particle size. Pharmaceutical Research. 1996; 13(12):1838–45. PMID: 8987081
29. Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, et al. Hydrophilic poly(dl-lactide-co-glycolide)
microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. Journal of
Controlled Release. 2001 Sep 11; 76(1–2):149–68. PMID: 11532321
30. Pappo J, Ermak TH. Uptake and translocation of fluorescent latex particles by rabbit Peyer’s patch folli-
cle epithelium: a quantitative model for M cell uptake. Clinical and experimental immunology. 1989; 76
(1):144–8. PMID: 2661061
31. Kraehenbuhl J-P, Neutra MR. Epithelial M cells: differentiation and function. Annual Review of Cell and
Developmental Biology. 2000; 16(1):301–32.
32. Apter FM, Michetti P, Winner LS, Mack JA, Mekalanos JJ, Neutra MR. Analysis of the roles of antilipo-
polysaccharide and anti-cholera toxin immunologlubulin A (IgA) antibodies in protection against Vibrio
cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infection and Immunity. 1993;
61(12):5279–85. PMID: 8225601
33. Walker RI, Schmauder-Chock EA, Parker JL, Burr D. Selective association and transport of Campylo-
bacter jejuni through M cells of rabbit Peyer’s patches. Canadian journal of microbiology. 1988; 34
(10):1142–7. PMID: 3196964
Functional M Cells from Human Intestinal Stem Cells
PLOS ONE | DOI:10.1371/journal.pone.0148216 January 28, 2016 15 / 16
34. Grützkau a, Hanski C, Hahn H, Riecken EO. Involvement of M cells in the bacterial invasion of Peyer’s
patches: a commonmechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria.
Gut. 1990; 31(9):1011–5. PMID: 2210445
35. Vallin J, Thuret R, Giacomello E, Faraldo MM, Thiery JP, Broders F. Cloning and Characterization of
Three Xenopus Slug Promoters Reveal Direct Regulation by Lef/β-Catenin Signaling. Journal of Bio-
logical Chemistry. 2001; 276(32):30350–8. PMID: 11402039
36. Willert K, Brown JD, Danenberg E, Duncan AW,Weissman IL, Reya T, et al. Wnt proteins are lipid-
modified and can act as stem cell growth factors. Nature. 2003; 423(6938):448–52. PMID: 12717451
37. Ma L, Zhang G, Doyle MP. Green Fluorescent Protein Labeling of Listeria, Salmonella, and Escherichia
coli O157:H7 for Safety-Related Studies. PLoS ONE. 2011; 6(4):e18083. doi: 10.1371/journal.pone.
0018083 PMID: 21483738
Functional M Cells from Human Intestinal Stem Cells
PLOS ONE | DOI:10.1371/journal.pone.0148216 January 28, 2016 16 / 16
